As of early 2026, compounded GLP-1 medications remain available through licensed pharmacies in many jurisdictions, but the long-term future of GLP-1 compounding depends on factors including manufacturer supply levels, ongoing litigation outcomes, and potential Congressional action
Retesting labs at regular intervals (e.g
GLP-1 Receptor Agonists GLP-1 receptor agonists (GLP-1 RAs) are based on analogs of the human molecule that are resistant to DPP-4, or a molecule derived from the saliva of the Gila monster lizard (!)
Saxenda (liraglutide) Saxenda is a GLP-1 medication appropriate for adults who: Have obesity (BMI of 30 or above) Have overweight (BMI of 27 or above) along with a weight-related comorbid condition like high blood pressure, type 2 diabetes, or high cholesterol or triglycerides It is also approved for children ages 12 and above who weigh more than 132 pounds and are considered obese
[DOI] [PubMed] [Google Scholar] 55.Garca-Pieres A.J., Lindenmeyer M.T., Merfort I
(never got that either) And the most strange thing is that it feels really good to stretch, like when you first wake up